Franklin Resources Inc Ligand Pharmaceuticals Inc Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 15,686 shares of LGND stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,686

Previous 13,939 12.53%

Holding current value

$1.65 Million

Previous $1.02 Million 29.76%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$68.53 - $87.91 $119,721 - $153,578	1,747 Added 12.53%	15,686 $1.32 Million
Q1 2024 May 13, 2024	SELL	$68.64 - $89.2 $8,717 - $11,328	-127 Reduced 0.9%	13,939 $1.02 Million
Q4 2023 Feb 09, 2024	BUY	$49.57 - $72.63 $21,711 - $31,811	438 Added 3.21%	14,066 $1 Million
Q3 2023 Nov 13, 2023	BUY	$58.86 - $72.67 $246,682 - $304,559	4,191 Added 44.41%	13,628 $816,000
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $656,154 - $748,637	9,437 New	9,437 $680,000
Q2 2022 Aug 11, 2022	SELL	$74.52 - $117.06 $22,132 - $34,766	-297 Reduced 11.55%	2,275 $203,000
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $2,944 - $4,698	31 Added 1.22%	2,572 $290,000
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $24,516 - $31,843	192 Added 8.17%	2,541 $392,000
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $80,943 - $114,481	791 Added 50.77%	2,349 $328,000
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $11,303 - $15,563	100 Added 6.86%	1,558 $204,000
Q1 2021 May 13, 2021	BUY	$99.52 - $215.83 $145,100 - $314,680	1,458 New	1,458 $223,000

Others Institutions Holding LGND

# of Institutions

247

Shares Held

17.5M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.77B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Ligand Pharmaceuticals Inc Transaction History